Evidence map›Paper›PMID 33028480›Full record

Trial reportJournal of studies on alcohol and drugs2020

Mentorship for Addiction Problems (MAP): A New Behavioral Intervention to Assist in the Treatment of Substance Use Disorders.

Kathlene Tracy, Leah Wachtel, Emily Goldmann, Joseph Nissenfeld, Mark Burton, Marc Galanter, Samuel A Ball

Open access · greenAbstract readComparative StudyRandomized Controlled Trial
PubMed Full text at PMC
In one paragraph

Trial report in Journal of studies on alcohol and drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Kathlene TracyPsychosocial Division, Addiction Institute Mount Sinai (AIMS), Laboratory of Psychosocial Processes in Addiction, Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, New York.
Leah WachtelPsychosocial Division, Addiction Institute Mount Sinai (AIMS), Laboratory of Psychosocial Processes in Addiction, Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, New York.
Emily GoldmannCollege of Global Public Health, New York University, New York, New York.
Joseph NissenfeldDivision of Alcoholism and Drug Abuse, New York University School of Medicine, Department of Psychiatry, New York, New York.
Mark BurtonDivision of Alcoholism and Drug Abuse, New York University School of Medicine, Department of Psychiatry, New York, New York.
Marc GalanterDivision of Alcoholism and Drug Abuse, New York University School of Medicine, Department of Psychiatry, New York, New York.
Samuel A BallYale University School of Medicine, Department of Psychiatry, New Haven, Connecticut.
New York University · USIcahn School of Medicine at Mount Sinai · USNew York College of Health Professions · USYale University · US

Funding

Mentorship for Alcohol Problems (MAP)R01AA016160 · NIAAA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TRACY, KATHLENE · 2007 to 2009
$1.1M
A Stage Ib Randomized Pilot Study of Mentorship for Addiction Problems (MAP)R34DA034898 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TRACY, KATHLENE · 2013 to 2014
$777k
NIAAA NIH HHS R01 AA016160NIDA NIH HHS R34 DA034898
6 · The paper itself

Abstract

objectiveMentorship for Addiction Problems (MAP) is a new behavioral treatment formalizing client-to-client mentorship relationships as an adjunct to standard outpatient substance use disorder treatment. We tested the preliminary efficacy of MAP in reducing substance use and associated barriers to successful treatment outcomes.

methodA total of 65 participants (17 later recovery participants [LRPs] and 48 early recovery participants [ERPs]) with substance use disorders were randomized to MAP + Treatment as Usual (TAU) or TAU alone. Within MAP, for each cohort, a pool of 4-5 mentors (LRPs) was formed and engaged in mentoring activities for 24 weeks until 12-13 mentees (ERPs), newly admitted, had participated in MAP for 12 weeks. Behavioral and biological measures were conducted at baseline, weekly, monthly, and termination for all participants and during the 12-week follow-up for ERPs.

resultsSubstance use declined across both conditions for ERPs (N = 48) during treatment, Weeks 0-12 (p = .001); however, on average, ERPs in the MAP intervention used significantly fewer days than controls during Treatment Weeks 1-12 (p = .013) and during Follow-Up Weeks 13-24 (p = .043). Addiction Severity Index alcohol and drug use scores increased in TAU and decreased in MAP during Follow-Up Weeks 13-24 for ERPs, alcohol: b = -0.08, SE = 0.03, t(47) = -2.97, p = .005; drug use: b = -0.02, SE = 0.01, t(47) = -2.36, p = .023. In addition, there was high patient interest in MAP and good fidelity to delivery of treatment.

conclusionsMAP shows promise assisting in the reduction of substance use early in treatment when vulnerability and risk for relapse is high and has a positive impact on serious problems undercutting addiction treatment efficacy.

Indexed as

MentorsAdultAmbulatory CareBehavior, AddictiveBehavior TherapyFemaleHumansMaleMiddle AgedRecurrenceSubstance-Related DisordersTreatment Outcome

Identifiers

PMID33028480
PMCPMC8076492
OpenAlexW3092628235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.